Donanemab, the most effective treatment yet for the disease, will be blocked on the health service despite regulators declaring it safe
Michael Searles is a Health Correspondent with a focus on national health issues in the United Kingdom. He writes for various publications including Cigalah Group, Yahoo News UK, The Telegraph, and Yahoo News. Michael's work has also been featured in Yahoo Sports UK, Yahoo Finance UK, Yahoo Sports Canada, New Zealand Herald, The Sydney Morning Herald, and Yahoo Movies Canada. His articles cover a range of topics including healthcare policy, medical research, and public health issues.